NCT02847286View on ClinicalTrials.gov

To Assess the Drug-drug Interaction Potential Between Dapivirine Vaginal Ring-004, Containing 25 mg of Dapivirine, and Clotrimazole 10 mg/g (1%)

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

November 28, 2016

Study Completion Date

November 28, 2016

Conditions
HIV- Prevention
Interventions
DRUG

Dapivirine Ring-004

Treatment A: Dapivirine Ring-004 for 28 days

DRUG

Dapivirine Ring-004 for 28 days along with clotrimazole

Treatment B: Dapivirine Ring-004 for 28 days along with clotrimazole, 5 g per day for 7 days

DRUG

Clotrimazole

Treatment C: Clotrimazole, 5 g per day for 7 days

All Listed Sponsors
lead

International Partnership for Microbicides, Inc.

INDUSTRY

NCT02847286 - To Assess the Drug-drug Interaction Potential Between Dapivirine Vaginal Ring-004, Containing 25 mg of Dapivirine, and Clotrimazole 10 mg/g (1%) | Biotech Hunter | Biotech Hunter